Ellis Andrea

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return 31% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ellis Andrea's trades of BridgeBio Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-13 2026-07-09
PlS Planned sale
54,261 +5.5%
298.28
US$2,588,871 		54,261 +5.5% 298.28 US$2,588,871
2026-07-09 2026-07-09
PrS Proposed sale
26,123
151.12
US$4,100,957 		26,123 151.12 US$4,100,957
2026-03-06 2026-03-04
PlS Planned sale
19,035 -17.0%
407.92
US$479,412 		19,035 -17.0% 407.92 US$479,412
2026-03-04 2026-03-04
PrS Proposed sale
64,921
64.87
US$4,211,300 		64,921 64.87 US$4,211,300
2025-08-07 2025-08-05
PlS Planned sale
17,167 -48.0%
49.00
US$841,183 		17,167 -48.0% 49.00 US$841,183
2025-08-05 2025-08-05
PrS Proposed sale
17,167
49.00
US$841,183 		17,167 49.00 US$841,183
2025-04-16 2025-04-14
PlS Planned sale
10,000 -45.5%
35.00
US$350,000 		10,000 -45.5% 35.00 US$350,000
2025-04-14 2025-04-14
PrS Proposed sale
10,000
35.00
US$350,000 		10,000 35.00 US$350,000
2025-04-03 2025-04-01
PlS Planned sale
30,000 -71.4%
34.05
US$1,021,500 		30,000 -71.4% 34.05 US$1,021,500
2025-04-02 2025-04-01
PrS Proposed sale
30,000
34.05
US$1,021,500 		30,000 34.05 US$1,021,500
2022-03-17 2022-03-15
B Purchase
12,000 +inf%
8.39
US$100,680 		12,000 +inf% 8.39 US$100,680